Solutions

Solutions

Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.

See solutions

WHAT WE DO

HOW WE DO IT

Overview

Portfolio management and asset valuation
- Building patient insights into assets, profile and claims
- Portfolio optimization
- Asset valuation and indication prioritization
- Early evidence review
- Integrated development strategy and planning
Early development and innovation
- Early Phase Clinical Trials
- Site Alliance Network and KOL Engagement
- Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD)
- Regulatory Strategy
- Real World Evidence
- Market Access Consulting, Strategy, and Delivery
- Dedicated early phase clinical units
- Biomarker and Genomic Medicine Strategy
- Integrated evidence generation planning
- Clinical Logistics
- Medical Communications
Integrated clinical development
- Phase IIB-IV Clinical Trial Solutions
- Real World Evidence
- Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD)
- Protocol-Driven, Customized Site Solution Strategy
- Patient Inclusion
- Regulatory Strategy, Submissions, Compliance, and Outsourcing
- Market Access Strategy and Delivery
- Clinical Logistics
- Clinical Development Technology Optimization
- Integrated evidence generation planning
- Medical Communications
- Drug Safety and Pharmacovigilance
Approval and access
- Global Regulatory Submissions and Outsourcing
- Real World Evidence
- Compliance and Risk Management
- Market Access Strategy and Delivery
- Integrated evidence generation planning
- Medical Communications
- Drug Safety and Pharmacovigilance
- Health economics modelling and simulation
Value substantiation lifecycle management
- Real-World Evidence, Market Access Strategy and Planning
- Regulatory Compliance
- Lifecycle Optimization
- Integrated evidence generation planning
- Medical Communications
FSP Integrated Solutions
- Gain an advantage through FSP
Operational excellence
Medical affairs for clinical trials
Clinical study start up
ParexelAI
- Parexel and Paradigm
- Leveraging AI in clinical development

Flexible, scalable solutions.

FSP Integrated Solutions

Our FSP solutions combine talent, expertise, technology, and global scale to help sponsors increase productivity, respond to changing pipeline demands, and bring therapies to patients faster.

Learn more

Biotech
Therapeutic Expertise

Therapeutic Expertise

Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.

See expertise

THERAPEUTIC EXPERTISE

CROSS-THERAPEUTIC EXPERTISE

Overview

Cell and gene therapy
General medicine
- Gastroenterology CRO
- Respiratory CRO
- Endocrine & Metabolic CRO
- Cardiovascular CRO
- Women's health CRO
Infectious disease and vaccines
- Critical Care
- Hepatitis B
- Novel treatments in infectious disease
- Vaccines
Immunology
- Dermatology CRO
- Allergy CRO
Oncology CRO
- Bladder cancer CRO
- Breast cancer CRO
- Colorectal cancer CRO
- Gynecologic cancer CRO
- Head and neck cancer CRO
- Liver cancer CRO
- Lung cancer CRO
- Pancreatic cancer CRO
- Phase I oncology CRO
- Prostate cancer CRO
Neuroscience
- Neurology
- Psychiatry
Pediatrics
Rare Diseases
Hematology
- Non-malignant hematology
- Malignant hematology CRO
Ophthalmology CRO

RELATED INSIGHTS

The evidence gap in hematology: From trial endpoints to patient outcomes

Learn more

Rethinking strategies for rescue treatment in wet AMD and retinal vascular disease clinical trials

Learn more

Insights

Insights

Our experts help you stay at the forefront of the industry — and ahead of change.

Learn more

FEATURED INSIGHTS

NEW MEDICINES, NOVEL INSIGHTS

PODCAST

Clinical Trialblazers

Step into the world of biotech leaders and hear the untold stories behind their journeys to bring breakthrough innovations to life.

Listen Now

Cell & Gene Unscripted

Honest conversations with the experts shaping what's next

Watch the series

Participate

Participate

Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.

Learn more

INTERESTED IN PARTICIPATING?

TRIAL SITES

Overview

Patient volunteers
- Advisory Council
Healthy volunteers
Patient advocacy groups
Patient stories

HEAR FROM REAL PATIENTS

Patient Stories

Clinical study participation represents a deeply personal decision with potentially far-reaching impact, as evidenced by these inspiring individual stories that highlight both the life-changing potential for participants and the broader advancement of healthcare for all.

Learn more

Sites
About

About

We are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.

About Parexel

Overview

Leadership team
- Board of Directors
Global reach
Our Inclusion Strategy
Our sustainability strategy
Compliance, tax & privacy
- Compliance & Ethics
- Tax Strategy
- Privacy Policy
- Cookies and other web tracking
- Supplier Data Privacy Requirements
- Terms of Use
- French Gender Pay Data
- UK Gender Pay Data
- UK Modern Slavery Act Statement
- Ireland Gender Pay Data
- Supplier Inclusion Policy
- Vulnerability Reporting Program
Meet us at an event
- Poster presentations at EHA 2026
- Parexel Biotech Incubator

Main Menu

Solutions

Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.

See solutions

WHAT WE DO

HOW WE DO IT

Overview

Portfolio management and asset valuation
- Building patient insights into assets, profile and claims
- Portfolio optimization
- Asset valuation and indication prioritization
- Early evidence review
- Integrated development strategy and planning
Early development and innovation
- Early Phase Clinical Trials
- Site Alliance Network and KOL Engagement
- Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD)
- Regulatory Strategy
- Real World Evidence
- Market Access Consulting, Strategy, and Delivery
- Dedicated early phase clinical units
- Biomarker and Genomic Medicine Strategy
- Integrated evidence generation planning
- Clinical Logistics
- Medical Communications
Integrated clinical development
- Phase IIB-IV Clinical Trial Solutions
- Real World Evidence
- Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD)
- Protocol-Driven, Customized Site Solution Strategy
- Patient Inclusion
- Regulatory Strategy, Submissions, Compliance, and Outsourcing
- Market Access Strategy and Delivery
- Clinical Logistics
- Clinical Development Technology Optimization
- Integrated evidence generation planning
- Medical Communications
- Drug Safety and Pharmacovigilance
Approval and access
- Global Regulatory Submissions and Outsourcing
- Real World Evidence
- Compliance and Risk Management
- Market Access Strategy and Delivery
- Integrated evidence generation planning
- Medical Communications
- Drug Safety and Pharmacovigilance
- Health economics modelling and simulation
Value substantiation lifecycle management
- Real-World Evidence, Market Access Strategy and Planning
- Regulatory Compliance
- Lifecycle Optimization
- Integrated evidence generation planning
- Medical Communications
FSP Integrated Solutions
- Gain an advantage through FSP
Operational excellence
Medical affairs for clinical trials
Clinical study start up
ParexelAI
- Parexel and Paradigm
- Leveraging AI in clinical development

Flexible, scalable solutions.

FSP Integrated Solutions

Our FSP solutions combine talent, expertise, technology, and global scale to help sponsors increase productivity, respond to changing pipeline demands, and bring therapies to patients faster.

Learn more

Therapeutic Expertise

Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.

See expertise

THERAPEUTIC EXPERTISE

CROSS-THERAPEUTIC EXPERTISE

Overview

Cell and gene therapy
General medicine
- Gastroenterology CRO
- Respiratory CRO
- Endocrine & Metabolic CRO
- Cardiovascular CRO
- Women's health CRO
Infectious disease and vaccines
- Critical Care
- Hepatitis B
- Novel treatments in infectious disease
- Vaccines
Immunology
- Dermatology CRO
- Allergy CRO
Oncology CRO
- Bladder cancer CRO
- Breast cancer CRO
- Colorectal cancer CRO
- Gynecologic cancer CRO
- Head and neck cancer CRO
- Liver cancer CRO
- Lung cancer CRO
- Pancreatic cancer CRO
- Phase I oncology CRO
- Prostate cancer CRO
Neuroscience
- Neurology
- Psychiatry
Pediatrics
Rare Diseases
Hematology
- Non-malignant hematology
- Malignant hematology CRO
Ophthalmology CRO

RELATED INSIGHTS

The evidence gap in hematology: From trial endpoints to patient outcomes

Learn more

Rethinking strategies for rescue treatment in wet AMD and retinal vascular disease clinical trials

Learn more

Insights

Our experts help you stay at the forefront of the industry — and ahead of change.

Learn more

FEATURED INSIGHTS

NEW MEDICINES, NOVEL INSIGHTS

PODCAST

Clinical Trialblazers

Step into the world of biotech leaders and hear the untold stories behind their journeys to bring breakthrough innovations to life.

Listen Now

Cell & Gene Unscripted

Honest conversations with the experts shaping what's next

Watch the series

Participate

Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.

Learn more

INTERESTED IN PARTICIPATING?

TRIAL SITES

Overview

Patient volunteers
- Advisory Council
Healthy volunteers
Patient advocacy groups
Patient stories

HEAR FROM REAL PATIENTS

Patient Stories

Learn more

About

We are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.

About Parexel

Overview

Leadership team
- Board of Directors
Global reach
Our Inclusion Strategy
Our sustainability strategy
Compliance, tax & privacy
- Compliance & Ethics
- Tax Strategy
- Privacy Policy
- Cookies and other web tracking
- Supplier Data Privacy Requirements
- Terms of Use
- French Gender Pay Data
- UK Gender Pay Data
- UK Modern Slavery Act Statement
- Ireland Gender Pay Data
- Supplier Inclusion Policy
- Vulnerability Reporting Program
Meet us at an event
- Poster presentations at EHA 2026
- Parexel Biotech Incubator

The evidence gap in hematology: From trial endpoints to patient outcomes

Published on: Oct 1, 2026

Hematology trials are becoming increasingly complex as targeted therapies narrow patient populations and intensify competition for eligible participants. In this Parexel-sponsored webinar, our multidisciplinary panel will explore how early RWD/RWE planning, fit-for-purpose evidence, global regulatory strategy, and operational excellence are reshaping hematology development and market access.

Join Parexel experts to learn how sponsors are using real-world insights to improve feasibility, strengthen evidence generation, support regulatory and payer strategies, identify high-performing sites, and accelerate start-up in competitive development landscapes.

Return to Insights Center

Related Insights

Case Study

Speed meets strategy: Delivering a critical FDA 1572 package in just seven days

Sep 9, 2026

Blog

Data without borders: Assessing China-only evidence for EMA approval – insights from ex-EMA and seasoned subject matter experts

Aug 19, 2026

Article

Case Study: Turning urgency into progress—Advancing new hope in AML

Jun 4, 2026

Playbook

Real‑world evidence as a strategic architecture for precision hematology

May 29, 2026

Playbook

Hematology trials demand data-driven feasibility, expert site selection, and hyper-efficient start-up

May 29, 2026

Playbook

Navigating regulatory divides: Strategic diplomacy in rare hematology

May 29, 2026

Playbook

Five strategies to build a better non-malignant hematology drug by listening to patients

May 29, 2026

Playbook

How smarter trial design can derisk and accelerate your malignant hematology asset

May 29, 2026

Playbook

At the turning point: Shaping the future of hematology

May 29, 2026

Blog

Bolster your investor narrative with RWE

Jan 26, 2026

CTB Video

JCA strategy: Predicting and prioritizing PICOs

Jan 22, 2026

Video

Three misconceptions about JCA

Jan 22, 2026

Related Insights

Case Study

Speed meets strategy: Delivering a critical FDA 1572 package in just seven days

Sep 9, 2026

Blog

Data without borders: Assessing China-only evidence for EMA approval – insights from ex-EMA and seasoned subject matter experts

Aug 19, 2026

Article

Case Study: Turning urgency into progress—Advancing new hope in AML

Jun 4, 2026

Playbook

Real‑world evidence as a strategic architecture for precision hematology

May 29, 2026

Playbook

Hematology trials demand data-driven feasibility, expert site selection, and hyper-efficient start-up

May 29, 2026

Playbook

Navigating regulatory divides: Strategic diplomacy in rare hematology

May 29, 2026

Playbook

Five strategies to build a better non-malignant hematology drug by listening to patients

May 29, 2026

Playbook

How smarter trial design can derisk and accelerate your malignant hematology asset

May 29, 2026

Playbook

At the turning point: Shaping the future of hematology

May 29, 2026

Blog

Bolster your investor narrative with RWE

Jan 26, 2026

CTB Video

JCA strategy: Predicting and prioritizing PICOs

Jan 22, 2026

Video

Three misconceptions about JCA

Jan 22, 2026

Back

Access exclusive insights

Harness the power of clinical development with exclusive insights from our experts at Parexel

First Name *

Last Name *

Company *

Job Title *

Email *

Solutions

WHAT WE DO

HOW WE DO IT

Portfolio management and asset valuation

Early development and innovation

Integrated clinical development

Approval and access

Value substantiation lifecycle management

ParexelAI™

Flexible, scalable solutions.

Therapeutic Expertise

THERAPEUTIC EXPERTISE

CROSS-THERAPEUTIC EXPERTISE

General medicine

Infectious disease and vaccines

Immunology

Oncology

Neuroscience

Hematology

RELATED INSIGHTS

Insights

FEATURED INSIGHTS

NEW MEDICINES, NOVEL INSIGHTS

PODCAST

Cell & Gene Unscripted

Participate

INTERESTED IN PARTICIPATING?

TRIAL SITES

Patient volunteers

HEAR FROM REAL PATIENTS

About

Leadership team

Compliance, tax & privacy

Solutions

WHAT WE DO

HOW WE DO IT

Portfolio management and asset valuation

Early development and innovation

Integrated clinical development

Approval and access

Value substantiation lifecycle management

ParexelAI™

Flexible, scalable solutions.

Therapeutic Expertise

THERAPEUTIC EXPERTISE

CROSS-THERAPEUTIC EXPERTISE

General medicine

Infectious disease and vaccines

Immunology

Oncology

Neuroscience

Hematology

RELATED INSIGHTS

Insights

FEATURED INSIGHTS

NEW MEDICINES, NOVEL INSIGHTS

PODCAST

Cell & Gene Unscripted

Participate

INTERESTED IN PARTICIPATING?

TRIAL SITES

Patient volunteers

HEAR FROM REAL PATIENTS

About

Leadership team

Compliance, tax & privacy

The evidence gap in hematology: From trial endpoints to patient outcomes

Access exclusive insights